Article
The combination of Asp519Val/Glu665Val and Lys1813Ala mutations in FVIII markedly increases coagulation potential.
Blood advances - 13 Aug 2024
Nakajima Yuto, Oda Akihisa, Baatartsogt Nemekhbayar, Kashiwakura Yuji, Ohmori Tsukasa, Nogami Keiji
Abstract excerpt
ABSTRACT: A2 domain dissociation in activated factor VIII (FVIIIa) results in reduced activity. Previous studies demonstrated that some FVIII mutants (D519V/E665V and K1813A) with delayed A2 dissociation enhanced coagulation potential. We speculated, therefore, that FVIII encompassing a combination of these mutations might further enhance coagulant activity. The aim was to assess the D519V/E665V/K1813A-FVIII...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
